| Financial Year |
March 31 2023 |
| Monetary Funds |
808,419,230.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
128,875,966.86 |
| Accounts Receivable |
1,430,891,097.87 |
| Advances to Suppliers |
82,569,539.11 |
| Other Receivables |
65,979,470.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
727,542,142.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
158,028,610.03 |
| Other Current Assets |
-- |
| Total Current Assets |
3,467,417,257.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
63,495,842.93 |
| Investment Properties |
-- |
| Fixed Assetes |
2,682,882,160.52 |
| Under-construction Projects |
248,024,909.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
378,391,163.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
110,788,224.34 |
| Other Non-Current Assets |
79,312,736.02 |
| Sub-Total of Non-Current Assets |
3,569,695,036.82 |
| Total Assets |
7,037,112,294.63 |
| Short-Term Loans |
1,812,879,917.33 |
| Trading Financial liabilities |
43,400.00 |
| Notes Payable |
544,077,075.78 |
| Accounts Payable |
666,757,307.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
76,249,876.78 |
| Taxes Payable |
34,729,678.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
160,567,414.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
364,155,022.90 |
| Other Current Liabilities |
157,625.75 |
| Sub-Total of Current Liabilities |
3,693,959,312.19 |
| Long-term Loans |
199,618,444.44 |
| Bonds Payable |
481,777,526.95 |
| Long-Term Accounts Payable |
285,208,578.01 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
206,335,205.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,251,631,626.34 |
| Total Liabilities |
4,945,590,938.53 |
| Paid-In Capital(Or Share Stock) |
289,812,177.00 |
| Capital Surplus |
581,444,223.70 |
| Surplus Reserve |
105,174,006.65 |
| LESS:Treasury Stock |
6,324,847.50 |
| Undistributed Profits |
675,097,185.21 |
| Minority Stockholder's Interest |
348,538,254.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,742,983,101.96 |
| Owner's Equity（Stockholder's Equity） |
2,091,521,356.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,037,112,294.63 |
